Recent ENVB News
- Enveric Biosciences Presents Data Highlighting Development of EB-003 at European Behavioral Pharmacology Society Biennial Workshop • Business Wire • 09/26/2024 12:30:00 PM
- Enveric Biosciences Presents Data on Lead Product Candidate, EB-003, at 7th Neuropsychiatric Drug Summit • Business Wire • 09/25/2024 12:30:00 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 09/12/2024 01:35:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/12/2024 04:15:08 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/04/2024 10:43:27 PM
- Enveric Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference • Business Wire • 09/04/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/22/2024 12:00:16 PM
- Aries Science & Technology and Enveric Biosciences Announce Issuance of Key US Patent Under Aries’ License for Treatment of Radiation Dermatitis and Other Conditions • Business Wire • 08/13/2024 12:00:00 PM
- Enveric Biosciences Reports Second Quarter 2024 Financial and Corporate Results • Business Wire • 08/12/2024 09:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 09:13:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 09:05:46 PM
- Enveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed Orally • Business Wire • 07/25/2024 12:00:00 PM
- Aries Science & Technology and Enveric Biosciences Announce Licensing Agreement • Business Wire • 07/15/2024 01:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 12:00:39 PM
- Enveric Biosciences Announces Patent Granted for Drug Candidate • Business Wire • 07/10/2024 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/08/2024 09:10:29 PM
- Enveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development Candidate • Business Wire • 06/25/2024 12:00:00 PM
- Enveric Biosciences to Participate in BIO International Convention 2024 • Business Wire • 05/30/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 08:15:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 12:00:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 09:25:22 PM
- Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results • Business Wire • 05/15/2024 10:00:00 AM
- Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders • Business Wire • 05/14/2024 12:00:00 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM